Cargando…
Bacopa monnieri extract increases rat coronary flow and protects against myocardial ischemia/reperfusion injury
BACKGROUND: This study explored Bacopa monnieri, a medicinal Ayurvedic herb, as a cardioprotectant against ischemia/reperfusion injury using cardiac function and coronary flow as end-points. METHODS: In normal isolated rat hearts, coronary flow, left ventricular developed pressure, heart rate, and f...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319078/ https://www.ncbi.nlm.nih.gov/pubmed/28219356 http://dx.doi.org/10.1186/s12906-017-1637-z |
_version_ | 1782509312509214720 |
---|---|
author | Srimachai, Sirintorn Devaux, Sylvie Demougeot, Celine Kumphune, Sarawut Ullrich, Nina D. Niggli, Ernst Ingkaninan, Kornkanok Kamkaew, Natakorn Scholfield, C. Norman Tapechum, Sompol Chootip, Krongkarn |
author_facet | Srimachai, Sirintorn Devaux, Sylvie Demougeot, Celine Kumphune, Sarawut Ullrich, Nina D. Niggli, Ernst Ingkaninan, Kornkanok Kamkaew, Natakorn Scholfield, C. Norman Tapechum, Sompol Chootip, Krongkarn |
author_sort | Srimachai, Sirintorn |
collection | PubMed |
description | BACKGROUND: This study explored Bacopa monnieri, a medicinal Ayurvedic herb, as a cardioprotectant against ischemia/reperfusion injury using cardiac function and coronary flow as end-points. METHODS: In normal isolated rat hearts, coronary flow, left ventricular developed pressure, heart rate, and functional recovery were measured using the Langendorff preparation. Hearts were perfused with either (i) Krebs-Henseleit (normal) solution, (control), or with 30, 100 μg/ml B. monnieri ethanolic extract (30 min), or (ii) with normal solution or extract for 10 min preceding no-perfusion ischemia (30 min) followed by reperfusion (30 min) with normal solution. Infarct volumes were measured by triphenyltetrazolium staining. L-type Ca(2+)-currents (I(Ca, L)) were measured by whole-cell patching in HL-1 cells, a mouse atrial cardiomyocyte cell line. Cytotoxicity of B. monnieri was assessed in rat isolated ventricular myocytes by trypan blue exclusion. RESULTS: In normally perfused hearts, B. monnieri increased coronary flow by 63 ± 13% (30 μg/ml) and 216 ± 21% (100 μg/ml), compared to control (5 ± 3%) (n = 8–10, p < 0.001). B. monnieri treatment preceding ischemia/reperfusion improved left ventricular developed pressure by 84 ± 10% (30 μg/ml), 82 ± 10% (100 μg/ml) and 52 ± 6% (control) compared to pre- ischemia/reperfusion. Similarly, functional recovery showed a sustained increase. Moreover, B. monnieri (100 μg/ml) reduced the percentage of infarct size from 51 ± 2% (control) to 25 ± 2% (n = 6-8, p < 0.0001). B. monnieri (100 μg/ml) reduced I(Ca, L) by 63 ± 4% in HL-1 cells. Ventricular myocyte survival decreased at higher concentrations (50–1000 μg/ml) B. monnieri. CONCLUSIONS: B. monnieri improves myocardial function following ischemia/reperfusion injury through recovery of coronary blood flow, contractile force and decrease in infarct size. Thus this may lead to a novel cardioprotectant strategy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12906-017-1637-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5319078 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-53190782017-02-24 Bacopa monnieri extract increases rat coronary flow and protects against myocardial ischemia/reperfusion injury Srimachai, Sirintorn Devaux, Sylvie Demougeot, Celine Kumphune, Sarawut Ullrich, Nina D. Niggli, Ernst Ingkaninan, Kornkanok Kamkaew, Natakorn Scholfield, C. Norman Tapechum, Sompol Chootip, Krongkarn BMC Complement Altern Med Research Article BACKGROUND: This study explored Bacopa monnieri, a medicinal Ayurvedic herb, as a cardioprotectant against ischemia/reperfusion injury using cardiac function and coronary flow as end-points. METHODS: In normal isolated rat hearts, coronary flow, left ventricular developed pressure, heart rate, and functional recovery were measured using the Langendorff preparation. Hearts were perfused with either (i) Krebs-Henseleit (normal) solution, (control), or with 30, 100 μg/ml B. monnieri ethanolic extract (30 min), or (ii) with normal solution or extract for 10 min preceding no-perfusion ischemia (30 min) followed by reperfusion (30 min) with normal solution. Infarct volumes were measured by triphenyltetrazolium staining. L-type Ca(2+)-currents (I(Ca, L)) were measured by whole-cell patching in HL-1 cells, a mouse atrial cardiomyocyte cell line. Cytotoxicity of B. monnieri was assessed in rat isolated ventricular myocytes by trypan blue exclusion. RESULTS: In normally perfused hearts, B. monnieri increased coronary flow by 63 ± 13% (30 μg/ml) and 216 ± 21% (100 μg/ml), compared to control (5 ± 3%) (n = 8–10, p < 0.001). B. monnieri treatment preceding ischemia/reperfusion improved left ventricular developed pressure by 84 ± 10% (30 μg/ml), 82 ± 10% (100 μg/ml) and 52 ± 6% (control) compared to pre- ischemia/reperfusion. Similarly, functional recovery showed a sustained increase. Moreover, B. monnieri (100 μg/ml) reduced the percentage of infarct size from 51 ± 2% (control) to 25 ± 2% (n = 6-8, p < 0.0001). B. monnieri (100 μg/ml) reduced I(Ca, L) by 63 ± 4% in HL-1 cells. Ventricular myocyte survival decreased at higher concentrations (50–1000 μg/ml) B. monnieri. CONCLUSIONS: B. monnieri improves myocardial function following ischemia/reperfusion injury through recovery of coronary blood flow, contractile force and decrease in infarct size. Thus this may lead to a novel cardioprotectant strategy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12906-017-1637-z) contains supplementary material, which is available to authorized users. BioMed Central 2017-02-20 /pmc/articles/PMC5319078/ /pubmed/28219356 http://dx.doi.org/10.1186/s12906-017-1637-z Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Srimachai, Sirintorn Devaux, Sylvie Demougeot, Celine Kumphune, Sarawut Ullrich, Nina D. Niggli, Ernst Ingkaninan, Kornkanok Kamkaew, Natakorn Scholfield, C. Norman Tapechum, Sompol Chootip, Krongkarn Bacopa monnieri extract increases rat coronary flow and protects against myocardial ischemia/reperfusion injury |
title | Bacopa monnieri extract increases rat coronary flow and protects against myocardial ischemia/reperfusion injury |
title_full | Bacopa monnieri extract increases rat coronary flow and protects against myocardial ischemia/reperfusion injury |
title_fullStr | Bacopa monnieri extract increases rat coronary flow and protects against myocardial ischemia/reperfusion injury |
title_full_unstemmed | Bacopa monnieri extract increases rat coronary flow and protects against myocardial ischemia/reperfusion injury |
title_short | Bacopa monnieri extract increases rat coronary flow and protects against myocardial ischemia/reperfusion injury |
title_sort | bacopa monnieri extract increases rat coronary flow and protects against myocardial ischemia/reperfusion injury |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319078/ https://www.ncbi.nlm.nih.gov/pubmed/28219356 http://dx.doi.org/10.1186/s12906-017-1637-z |
work_keys_str_mv | AT srimachaisirintorn bacopamonnieriextractincreasesratcoronaryflowandprotectsagainstmyocardialischemiareperfusioninjury AT devauxsylvie bacopamonnieriextractincreasesratcoronaryflowandprotectsagainstmyocardialischemiareperfusioninjury AT demougeotceline bacopamonnieriextractincreasesratcoronaryflowandprotectsagainstmyocardialischemiareperfusioninjury AT kumphunesarawut bacopamonnieriextractincreasesratcoronaryflowandprotectsagainstmyocardialischemiareperfusioninjury AT ullrichninad bacopamonnieriextractincreasesratcoronaryflowandprotectsagainstmyocardialischemiareperfusioninjury AT niggliernst bacopamonnieriextractincreasesratcoronaryflowandprotectsagainstmyocardialischemiareperfusioninjury AT ingkaninankornkanok bacopamonnieriextractincreasesratcoronaryflowandprotectsagainstmyocardialischemiareperfusioninjury AT kamkaewnatakorn bacopamonnieriextractincreasesratcoronaryflowandprotectsagainstmyocardialischemiareperfusioninjury AT scholfieldcnorman bacopamonnieriextractincreasesratcoronaryflowandprotectsagainstmyocardialischemiareperfusioninjury AT tapechumsompol bacopamonnieriextractincreasesratcoronaryflowandprotectsagainstmyocardialischemiareperfusioninjury AT chootipkrongkarn bacopamonnieriextractincreasesratcoronaryflowandprotectsagainstmyocardialischemiareperfusioninjury |